OneAscent Wealth Management LLC Sells 1,490 Shares of STERIS plc (NYSE:STE)

OneAscent Wealth Management LLC cut its holdings in STERIS plc (NYSE:STE) by 52.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,366 shares of the medical equipment provider’s stock after selling 1,490 shares during the period. OneAscent Wealth Management LLC’s holdings in STERIS were worth $281,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Avalon Trust Co acquired a new stake in STERIS during the fourth quarter worth approximately $30,000. Human Investing LLC bought a new position in shares of STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC grew its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division increased its stake in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its position in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 137 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Performance

STE opened at $222.99 on Friday. The company has a market cap of $21.91 billion, a price-to-earnings ratio of 47.34 and a beta of 0.92. The company’s fifty day moving average price is $222.51 and its two-hundred day moving average price is $221.48. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.02%. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Analysts Set New Price Targets

STE has been the subject of a number of research reports. Stephens restated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.